GO:1905665 positive regulation of calcium ion import across plasma membrane

Calcium ions (Ca2+) are universal second messengers that control a vast array of cellular processes, from muscle contraction and neurotransmitter release to gene expression and cell death. The movement of Ca2+ from the extracellular space into the cytosol across the plasma membrane is a tightly regulated event, and the Gene Ontology (GO) term GO:1905665, positive regulation of calcium ion import across plasma membrane, captures any process that activates or increases the frequency, rate, or extent of this import. This term is a biological_process and is critical for understanding how cells decode calcium signals under physiological and pathological conditions. Research into GO:1905665 has revealed that positive regulation of calcium import is not a single linear pathway but a convergence point for numerous signaling cascades. For example, G-protein coupled receptor (GPCR) activation, store depletion, and membrane depolarization can all enhance calcium entry through distinct molecular mechanisms. The Yuanjiang decoction, a traditional Chinese medicine used for bradyarrhythmia, was shown by network pharmacology and LC-MS to modulate calcium import pathways, highlighting the term's relevance in drug discovery. For researchers, GO:1905665 provides a standardized framework to annotate genes and proteins that enhance calcium influx. Understanding this process is essential for dissecting cardiac rhythm disorders, neuronal excitability, immune cell activation, and cancer cell proliferation. This article synthesizes the current knowledge on the genes, mechanisms, and experimental models used to study positive regulation of calcium ion import across the plasma membrane.

GO:1905665, positive regulation of calcium ion import across plasma membrane, is defined by QuickGO as any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane. In simpler terms, it encompasses all molecular events that boost the movement of calcium ions from outside the cell to the inside through the plasma membrane. This term is a biological_process and is a child of the broader regulation of calcium ion import across plasma membrane. Synonyms include activation of calcium ion import across plasma membrane, up regulation of calcium ion import across plasma membrane, up-regulation of calcium ion import across plasma membrane, and upregulation of calcium ion import across plasma membrane.

Positive regulation of calcium ion import across the plasma membrane is fundamental to life because calcium signals control heartbeat, neuronal firing, muscle contraction, immune responses, and cell fate decisions. When this process is dysregulated, it can lead to severe pathologies such as bradyarrhythmia, heart failure, Alzheimer's disease, and cancer. The term GO:1905665 provides a precise annotation for genes and pathways that enhance calcium entry, enabling researchers to systematically study their roles in health and disease. Moreover, pharmacological modulation of calcium import is a proven therapeutic strategy, as evidenced by calcium channel blockers used for hypertension and arrhythmias. Network pharmacology studies, such as the one on Yuanjiang decoction for bradyarrhythmia, have identified active compounds that may act through positive regulation of calcium import, underscoring the term's translational value.

The following genes and proteins are key players in positive regulation of calcium ion import across the plasma membrane, based on their established roles in calcium signaling and their relevance to human disease.

Positive regulation of calcium ion import across the plasma membrane is itself tightly regulated by multiple signaling pathways. The phosphatidylinositol 3-kinase (PI3K)/Akt pathway can enhance calcium entry by promoting channel trafficking to the plasma membrane. Protein kinase A (PKA) and protein kinase C (PKC) phosphorylate voltage-gated calcium channels, increasing their open probability. Conversely, the integrated stress response (ISR) can suppress calcium import under conditions of ER stress. Store-operated calcium entry is regulated by the ER calcium sensor STIM1 and its modulator STIM2, as well as by CRACR2A and SARAF. In cardiac tissue, beta-adrenergic receptor signaling via GNAS and PRKACA enhances L-type calcium channel activity, a key mechanism for increasing heart rate and contractility. Network pharmacology studies of Yuanjiang decoction suggest that natural compounds may modulate these regulatory nodes to treat bradyarrhythmia.

Dysregulation of positive regulation of calcium import is directly linked to cardiac arrhythmias. Loss-of-function mutations in CACNA1C, encoding Cav1.2, cause Brugada syndrome and Timothy syndrome, which feature life-threatening arrhythmias. Bradyarrhythmia, characterized by an abnormally slow heart rate, can result from reduced calcium import in sinoatrial node cells. Yuanjiang decoction, a traditional Chinese medicine, has been studied for bradyarrhythmia using network pharmacology and LC-MS, revealing that its active compounds may target calcium import pathways to restore normal rhythm. This highlights the therapeutic potential of modulating GO:1905665 in cardiac disease.

In neurons, excessive or insufficient calcium import contributes to neurodegeneration. Overactivation of NMDA receptors and voltage-gated calcium channels leads to calcium overload, mitochondrial dysfunction, and apoptosis, as seen in Alzheimer's disease and Parkinson's disease. Conversely, impaired calcium import in cerebellar Purkinje cells is associated with spinocerebellar ataxia. Mutations in ITPR1, which encodes the IP3 receptor, cause Gillespie syndrome, a rare neurological disorder. Thus, precise regulation of calcium import is critical for neuronal survival and function.

Many cancer cells reprogram calcium signaling to support proliferation, migration, and survival. Overexpression of TRPC6, ORAI1, and STIM1 has been observed in breast, prostate, and colorectal cancers. Enhanced store-operated calcium entry promotes cell cycle progression and resistance to apoptosis. Targeting positive regulation of calcium import with inhibitors such as SKF-96365 or 2-APB has shown anti-tumor effects in preclinical models. Therefore, GO:1905665 is a promising area for cancer therapeutics.

Store-operated calcium entry is essential for T-cell activation and immune response. Loss-of-function mutations in ORAI1 or STIM1 cause severe combined immunodeficiency (SCID) with autoimmunity. In contrast, excessive calcium import can contribute to autoimmune diseases such as rheumatoid arthritis. Understanding the positive regulation of calcium import in immune cells may lead to new treatments for immunodeficiency and autoimmune disorders.

Calcium imaging using dyes such as Fura-2, Fluo-4, or genetically encoded calcium indicators (GECIs) like GCaMP allows real-time measurement of cytosolic calcium concentrations. This method is widely used to assess positive regulation of calcium import in response to agonists or membrane depolarization. In cardiac research, calcium imaging in isolated cardiomyocytes or iPSC-derived cardiomyocytes can reveal defects in calcium handling associated with arrhythmias.

Patch-clamp recordings measure the activity of individual calcium channels, including voltage-gated and store-operated channels. This technique provides precise information on channel open probability, conductance, and inactivation kinetics. It is essential for studying mutations in CACNA1C, ORAI1, and STIM1 that affect positive regulation of calcium import. For example, Timothy syndrome mutations in CACNA1C cause loss of voltage-dependent inactivation, leading to sustained calcium influx.

Genetically encoded calcium indicators (GECIs) such as GCaMP6 and FRET-based sensors like Cameleon enable non-invasive monitoring of calcium dynamics in live cells and organisms. These tools can be targeted to specific cellular compartments, such as the cytosol, ER, or mitochondria, to study compartmentalized calcium import. They are particularly useful for high-throughput screening of compounds that modulate GO:1905665.

Genome-wide CRISPR knockout or activation screens coupled with calcium-sensitive reporters can identify novel regulators of positive regulation of calcium import. For instance, a CRISPR activation screen using a NFAT-responsive luciferase reporter can uncover genes that enhance SOCE. Such screens have the power to reveal unanticipated players in calcium signaling and are increasingly used in cardiac and cancer research.

Researchers studying positive regulation of calcium ion import across plasma membrane-related genes often need to determine whether a candidate gene is causally involved in calcium influx, how disease mutations alter channel function, or whether enhancing or suppressing the pathway can reverse a disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.

GO:1905665, positive regulation of calcium ion import across plasma membrane, is a fundamental biological process that governs calcium signaling in health and disease. Its dysregulation contributes to cardiac arrhythmias, neurodegeneration, cancer, and immune disorders. Understanding the genes, mechanisms, and regulatory pathways involved is essential for developing targeted therapies. CRISPR-based models, combined with advanced imaging and screening technologies, offer powerful tools to dissect this process. EDITGENE provides comprehensive services to support researchers in this endeavor, from knockout and knock-in models to library screening and bioinformatics.